NCT05339789 Long-term Surgical Treatment Outcome of Peri-implantitis Lesions
| NCT ID | NCT05339789 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Malmö University |
| Condition | Peri-Implantitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 650 participants |
| Start Date | 2020-08-30 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 650 participants in total. It began in 2020-08-30 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The surgical treatment outcome of patients that have been or are consecutively treated at the University of Malmö, at Blekinge hospital, and at the Dental Clinic of the Sigmund Freud University Vienna will be evaluated on an a regular base; specifically all patients treated since 2014 and those receiving treatment in the future, will be regularly assessed, max. once per year after the 1-year control from the surgical intervention for clinical and radiographic assessment of healing. Clinical peri-implant parameters (e.g., probing pocket depth) and peri-implant sulcus fluid (PISF) are collected, and a peri-apical radiographic examination is made. Further, from 200 patients treated in the future, the inflammatory peri-implant lesion will be collected and subjected to histological, microbiological, and molecular analysis. The removal of these lesions is a standard procedure and performed in all patients independent of study participation; i.e., the lesion has anyway to be removed during surgery and if the lesions are not stored, they would be thrown.
Eligibility Criteria
Inclusion Criteria: * All patients being treated since 2014 and continuously being treated will be called in for regular check-ups after the surgical intervention and an examination for study purpose will be performed annually. Exclusion criteria: \- implant loss
Frequently Asked Questions
Who can join the NCT05339789 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 130 Years, studying Peri-Implantitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05339789 currently recruiting?
Yes, NCT05339789 is actively recruiting participants. Visit ClinicalTrials.gov or contact Malmö University to inquire about joining.
Where is the NCT05339789 trial being conducted?
This trial is being conducted at Vienna, Austria, Karlskrona, Sweden, Malmö, Sweden.
Who is sponsoring the NCT05339789 clinical trial?
NCT05339789 is sponsored by Malmö University. The trial plans to enroll 650 participants.